Rivastigmine - Novartis
At a glance
- Drug Originator Novartis
- Drug Licenced by AbbVie; Almirall S.A.; Biosintetica; Knight Therapeutics; Ono Pharmaceutical
- Drug Class Antidementias; Phenylcarbamates; Small molecules
- Mechanism of Action Acetylcholinesterase inhibitors; Butyrylcholinesterase inhibitors
- USA Patent Applicants NOVARTIS; SANDOZ
- USA Patents 4
- NDAs 3
- Patent Applications 4,624
Table of Contents
Disclaimer